惠泰医疗收盘下跌1.07%，滚动市盈率56.77倍，总市值406.54亿元

Core Viewpoint - The company Huatai Medical's stock closed at 288.3 yuan, down 1.07%, with a rolling PE ratio of 56.77 times, indicating a higher valuation compared to the industry average [1] Company Summary - Huatai Medical specializes in the research, production, and sales of electrophysiology and interventional medical devices, with key products including electrophysiology, coronary access, peripheral vascular intervention, and non-vascular interventional medical devices [1] - For Q1 2025, the company reported revenue of 564 million yuan, a year-on-year increase of 23.93%, and a net profit of 183 million yuan, up 30.69%, with a gross profit margin of 73.09% [1] Shareholder Information - As of March 31, 2025, Huatai Medical had 3,752 shareholders, a decrease of 267 from the previous period, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Industry Summary - The average PE ratio for the medical device industry is 51.42 times, with a median of 37.44 times, positioning Huatai Medical at the 89th rank within the industry [1][2] - The industry average market capitalization is 106.60 billion yuan, while Huatai Medical's total market capitalization is 40.654 billion yuan [2]